SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Jun-23 9:33 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 5,326 | $37.87 | $201,669.00 | (2%) 275.29K to 269.96K | |
07-Jun-23 9:33 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 5,058 | $38.99 | $197,216.00 | (2%) 280.35K to 275.29K | |
08-Jun-22 7:51 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Grant | 21,500 | -- | -- | 8% 272.26K to 293.76K | |
08-Jun-22 7:51 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Sale (Planned) | 13,828 | $59.85 | $827,658.00 | (5%) 293.76K to 279.94K | |
08-Jun-22 7:51 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-22 | Market Sale | 11,965 | $61.37 | $734,340.00 | (4%) 284.23K to 272.26K | < 1% |
02-May-22 6:34 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 28-Apr-22 | Option Exercise | 22,500 | $10.81 | $243,225.00 | 9% 261.73K to 284.23K | |
05-Apr-22 5:26 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 31-Mar-22 | Option Exercise | 22,500 | $10.81 | $243,225.00 | 9% 239.23K to 261.73K | |
27-Jan-22 4:27 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 25-Jan-22 | Option Exercise | 13,670 | $10.81 | $147,773.00 | 6% 225.56K to 239.23K | |
13-Jan-22 4:11 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 11-Jan-22 | Option Exercise | 15,000 | $10.81 | $162,150.00 | 7% 210.56K to 225.56K | |
18-Nov-21 4:22 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Nov-21 | Option Exercise | 15,000 | $10.81 | $162,150.00 | 8% 195.27K to 210.27K | |
05-Aug-21 5:51 PM View: | Chiasma, Inc (CHMA) | 05-Aug-21 | Disposition | 25,000 | -- | -- | (100%) 25.0K to 0 | |
11-Jun-21 8:38 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-21 | Grant | 17,800 | -- | -- | 10% 177.34K to 195.14K | |
07-Jun-21 9:53 PM View: | Amarin Corp Plc\uk (AMRN) | 04-Jun-21 | Market Purchase | 10,000 | $4.53 | $45,350.00 | 33% 30.0K to 40.0K | (2%) |
08-Jun-21 4:18 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-21 | Market Sale | 14,905 | $61.04 | $909,756.00 | (8%) 192.25K to 177.34K | (1%) |
07-Jun-21 9:53 PM View: | Amarin Corp Plc\uk (AMRN) | 03-Jun-21 | Market Purchase | 5,000 | $4.62 | $23,115.00 | 20% 25.0K to 30.0K | (4%) |
13-May-21 6:01 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-May-21 | Option Exercise | 21,250 | $10.81 | $229,713.00 | 11% 192.25K to 213.5K | |
13-May-21 6:01 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-May-21 | Market Option Sale (Planned) | 21,250 | $61.95 | $1,316,470.00 | (10%) 213.5K to 192.25K | |
13-May-21 6:01 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 11-May-21 | Option Exercise | 21,250 | $10.81 | $229,713.00 | 11% 192.25K to 213.5K | |
13-May-21 6:01 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 11-May-21 | Market Option Sale (Planned) | 21,250 | $60.93 | $1,294,830.00 | (10%) 213.5K to 192.25K | |
13-May-21 6:01 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 24-Mar-21 | Gift | 1,080 | -- | -- | (< 1%) 193.32K to 192.25K | |
04-Feb-21 7:58 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Feb-21 | Option Exercise | 21,250 | $10.81 | $229,713.00 | 11% 193.32K to 214.57K | |
04-Feb-21 7:58 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Feb-21 | Market Option Sale (Planned) | 21,250 | $71.21 | $1,513,260.00 | (10%) 214.57K to 193.32K | |
04-Feb-21 7:58 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Feb-21 | Option Exercise | 21,250 | $10.81 | $229,713.00 | 11% 193.32K to 214.57K | |
04-Feb-21 7:58 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Feb-21 | Market Option Sale (Planned) | 21,250 | $69.41 | $1,474,870.00 | (10%) 214.57K to 193.32K | |
02-Dec-20 8:05 PM View: | Amarin Corp Plc\uk (AMRN) | 30-Nov-20 | Market Purchase | 25,000 | $4.86 | $121,518.00 | 100% 0 to 25.0K | |
01-Dec-20 7:40 PM View: | Chiasma, Inc (CHMA) | 30-Nov-20 | Market Purchase | 25,000 | $4.27 | $106,858.00 | 100% 0 to 25.0K | (6%) |
16-Oct-20 4:26 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Oct-20 | Option Exercise | 30,000 | $10.81 | $324,300.00 | 16% 193.18K to 223.18K | |
16-Oct-20 4:26 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Oct-20 | Market Option Sale (Planned) | 30,000 | $55.56 | $1,666,800.00 | (13%) 223.18K to 193.18K | (7%) |
16-Oct-20 4:26 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Oct-20 | Option Exercise | 30,000 | $10.81 | $324,300.00 | 16% 193.18K to 223.18K | |
16-Oct-20 4:26 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Oct-20 | Market Option Sale (Planned) | 30,000 | $55.00 | $1,650,000.00 | (13%) 223.18K to 193.18K | (8%) |
16-Oct-20 4:26 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Oct-20 | Option Exercise | 30,000 | $10.81 | $324,300.00 | 16% 193.18K to 223.18K | |
16-Oct-20 4:26 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Oct-20 | Market Option Sale (Planned) | 30,000 | $55.53 | $1,665,900.00 | (13%) 223.18K to 193.18K | (7%) |
19-Aug-20 5:44 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 17-Aug-20 | Market Sale (Planned) | 15,000 | $61.91 | $928,619.00 | (7%) 208.18K to 193.18K | 4% |
17-Jul-20 5:44 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Jul-20 | Market Sale (Planned) | 12,000 | $56.88 | $682,560.00 | (5%) 220.18K to 208.18K | (4%) |
11-Jun-20 6:34 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-20 | Grant | 33,300 | -- | -- | 18% 186.71K to 220.01K | |
08-Jun-20 9:09 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-20 | Market Sale | 17,111 | $48.12 | $823,402.00 | (8%) 203.82K to 186.71K | (23%) |
08-Jun-20 9:09 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 04-Jun-20 | Market Sale | 14,314 | $46.33 | $663,182.00 | (7%) 218.14K to 203.82K | (28%) |
25-Feb-20 4:55 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 21-Feb-20 | Option Exercise | 35,856 | $3.38 | $121,189.00 | 20% 182.28K to 218.14K | |
17-Jan-20 6:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Jan-20 | Option Exercise | 25,000 | $10.81 | $270,250.00 | 14% 182.28K to 207.28K | |
17-Jan-20 6:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Jan-20 | Market Option Sale (Planned) | 25,000 | $42.68 | $1,066,970.00 | (12%) 207.28K to 182.28K | (39%) |
30-Dec-19 4:05 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 26-Dec-19 | Option Exercise | 20,000 | $3.55 | $71,000.00 | 12% 162.1K to 182.1K | |
19-Nov-19 4:16 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Nov-19 | Option Exercise | 25,000 | $10.81 | $270,250.00 | 12% 207.1K to 232.1K | |
19-Nov-19 4:16 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Nov-19 | Market Option Sale (Planned) | 25,000 | $42.81 | $1,070,250.00 | (11%) 232.1K to 207.1K | (38%) |
19-Nov-19 4:16 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Nov-19 | Market Sale (Planned) | 20,000 | $42.81 | $856,200.00 | (10%) 207.1K to 187.1K | (38%) |
19-Nov-19 4:16 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Nov-19 | Market Sale (Planned) | 25,000 | $42.81 | $1,070,250.00 | (13%) 187.1K to 162.1K | (38%) |
04-Oct-19 4:31 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 02-Oct-19 | Option Exercise | 17,000 | $3.89 | $66,170.00 | 9% 190.1K to 207.1K | |
20-Sep-19 5:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 18-Sep-19 | Option Exercise | 14,000 | $3.41 | $47,760.00 | 8% 176.1K to 190.1K | |
16-Aug-19 4:19 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Aug-19 | Option Exercise | 12,849 | $10.81 | $138,898.00 | 7% 176.1K to 188.95K | |
16-Aug-19 4:19 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Aug-19 | Market Option Sale (Planned) | 12,849 | $39.15 | $503,092.00 | (7%) 188.95K to 176.1K | (51%) |
12-Jul-19 8:03 PM View: | Amarin Corp Plc\uk (AMRN) | 11-Jul-19 | Option Exercise | 51,991 | $2.33 | $121,035.00 | 100% 0 to 51.99K |